MedPath

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu

Effect of Carvedilol on Exercise Performance in Fontan Patients

Phase 4
Completed
Conditions
Single Ventricle
Fontan
Interventions
Drug: Placebo
First Posted Date
2016-10-27
Last Posted Date
2021-01-22
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
26
Registration Number
NCT02946892
Locations
🇺🇸

University of Texas Southwestern, Dallas, Texas, United States

Levothyroxine Replacement With Liquid Gel Capsules vs Tablets Post-thyroidectomy

Phase 4
Terminated
Conditions
Thyroid Cancer
Postsurgical Hypothyroidism
Interventions
First Posted Date
2016-10-27
Last Posted Date
2020-12-01
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
14
Registration Number
NCT02946918
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System

Not Applicable
Completed
Conditions
Breast Cancer
Colorectal Cancer
Interventions
Other: Care Coordination Strategies
First Posted Date
2016-10-24
Last Posted Date
2024-03-06
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
4322
Registration Number
NCT02943265
Locations
🇺🇸

UT Southwestern Medical Center Department of Population and Data Sciences, Dallas, Texas, United States

Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.

Phase 1
Completed
Conditions
Non-Small Cell Lung Carcinoma
Interventions
First Posted Date
2016-10-04
Last Posted Date
2024-02-21
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
23
Registration Number
NCT02922777
Locations
🇺🇸

Covenant Health Systems/Joe Arrington Cancer Treatment and Research Center, Lubbock, Texas, United States

🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Dallas 2K: A Natural History Study of Depression

Recruiting
Conditions
Depression, Bipolar
Depression
Interventions
Other: Observational Study
First Posted Date
2016-09-29
Last Posted Date
2025-05-04
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
2500
Registration Number
NCT02919280
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Aripiprazole for Bipolar Disorder and Alcohol Use Disorder

Phase 3
Completed
Conditions
Alcoholism
Bipolar Disorder
Alcohol Abuse
Interventions
Drug: Placebo
First Posted Date
2016-09-28
Last Posted Date
2023-08-02
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
132
Registration Number
NCT02918370
Locations
🇺🇸

UT Southwestern, Dallas, Texas, United States

A Clinical Trial of Patients With Melanoma

Phase 1
Withdrawn
Conditions
Melanoma
Interventions
First Posted Date
2016-09-27
Last Posted Date
2018-05-15
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT02915666
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Risk Reduction for Alzheimer's Disease

Phase 2
Completed
Conditions
Cognitively Normal Older Adults
Hypertension
Subjective Cognitive Decline
Family History of Alzheimer's Disease
Interventions
Behavioral: Aerobic Exercise Training
Other: Usual Care
Behavioral: Stretching Exercise
First Posted Date
2016-09-26
Last Posted Date
2022-02-15
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
513
Registration Number
NCT02913664
Locations
🇺🇸

University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States

🇺🇸

Washington University in St. Louis, Saint Louis, Missouri, United States

🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

and more 1 locations

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Phase 1
Terminated
Conditions
Cancer of Pancreas
Interventions
First Posted Date
2016-09-15
Last Posted Date
2024-06-03
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
14
Registration Number
NCT02902484
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

High Dose Rate Brachyablation of Primary Liver Lesions

Phase 1
Terminated
Conditions
Liver Cancer
Interventions
Radiation: brachytherapy
First Posted Date
2016-09-09
Last Posted Date
2021-05-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
1
Registration Number
NCT02893982
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath